Amyloid SUVR quantification methods | ||||||
Diagnosis | Brain region | MR-based | Generated MR-based | Normal PET template–based | Multiatlas PET template–based | PET segmentation–based |
Normal controls | Cortical | 1.29 ± 0.18 | 1.28 ± 0.17* | 1.04 ± 0.11† | 1.17 ± 0.17† | 1.24 ± 0.14† |
Frontal | 1.27 ± 0.18 | 1.26 ± 0.18* | 1.00 ± 0.12† | 1.12 ± 0.17† | 1.22 ± 0.14† | |
Cingulate | 1.52 ± 0.23 | 1.50 ± 0.24* | 1.24 ± 0.17† | 1.48 ± 0.25‡ | 1.41 ± 0.20† | |
Superior parietal | 1.49 ± 0.23 | 1.49 ± 0.25* | 1.17 ± 0.18† | 1.45 ± 0.26† | 1.38 ± 0.20† | |
Lateral temporal | 1.30 ± 0.18 | 1.32 ± 0.18‡ | 1.07 ± 0.10† | 1.20 ± 0.17† | 1.26 ± 0.14† | |
MCI | Cortical | 1.34 ± 0.20 | 1.32 ± 0.18‡ | 1.05 ± 0.10† | 1.21 ± 0.18† | 1.26 ± 0.15† |
Frontal | 1.32 ± 0.20 | 1.30 ± 0.17‡ | 1.05 ± 0.10† | 1.16 ± 0.17† | 1.23 ± 0.14† | |
Cingulate | 1.57 ± 0.26 | 1.57 ± 0.25* | 1.27 ± 0.17† | 1.57 ± 0.27* | 1.45 ± 0.22† | |
Superior parietal | 1.55 ± 0.27 | 1.55 ± 0.27* | 1.22 ± 0.21† | 1.53 ± 0.30* | 1.42 ± 0.23† | |
Lateral temporal | 1.35 ± 0.22 | 1.35 ± 0.21* | 1.08 ± 0.11† | 1.23 ± 0.19† | 1.28 ± 0.17† | |
Alzheimer dementia | Cortical | 1.41 ± 0.19 | 1.41 ± 0.18* | 1.08 ± 0.12† | 1.32 ± 0.16† | 1.35 ± 0.15† |
Frontal | 1.40 ± 0.20 | 1.38 ± 0.18* | 1.04 ± 0.13† | 1.29 ± 0.17† | 1.31 ± 0.15† | |
Cingulate | 1.74 ± 0.21 | 1.73 ± 0.22* | 1.37 ± 0.16† | 1.76 ± 0.22* | 1.59 ± 0.16† | |
Superior parietal | 1.73 ± 0.25 | 1.72 ± 0.26* | 1.35 ± 0.21† | 1.74 ± 0.27* | 1.57 ± 0.20† | |
Lateral temporal | 1.43 ± 0.18 | 1.45 ± 0.18* | 1.12 ± 0.12† | 1.34 ± 0.15† | 1.38 ± 0.15† |